Generic selectors
Exact matches only
Search in title
Search in content
Search in posts
Search in pages
Filter by Categories
15th National Conference of the IAOMFP, Chennai, 2006
Abstract
Abstracts from current literature
Acne in India: Guidelines for management - IAA Consensus Document
Addendum
Announcement
Art & Psychiatry
Article
Articles
Association Activities
Association Notes
Award Article
Book Review
Brief Report
Case Analysis
Case Letter
Case Letters
Case Notes
Case Report
Case Reports
Clinical and Laboratory Investigations
Clinical Article
Clinical Studies
Clinical Study
Commentary
Conference Oration
Conference Summary
Continuing Medical Education
Correspondence
Corrigendum
Cosmetic Dermatology
Cosmetology
Current Best Evidence
Current View
Derma Quest
Dermato Surgery
Dermatopathology
Dermatosurgery Specials
Dispensing Pearl
Do you know?
Drug Dialogues
e-IJDVL
Editor Speaks
Editorial
Editorial Remarks
Editorial Report
Editorial Report - 2007
Editorial report for 2004-2005
Errata
Erratum
Focus
Fourth All India Conference Programme
From Our Book Shelf
From the Desk of Chief Editor
General
Get Set for Net
Get set for the net
Guest Article
Guest Editorial
History
How I Manage?
IADVL Announcement
IADVL Announcements
IJDVL Awards
IJDVL AWARDS 2015
IJDVL Awards 2018
IJDVL Awards 2019
IJDVL Awards 2020
IJDVL International Awards 2018
Images in Clinical Practice
In Memorium
Inaugural Address
Index
Knowledge From World Contemporaries
Leprosy Section
Letter in Response to Previous Publication
Letter to Editor
Letter to the Editor
Letter to the Editor - Case Letter
Letter to the Editor - Letter in Response to Published Article
LETTER TO THE EDITOR - LETTERS IN RESPONSE TO PUBLISHED ARTICLES
Letter to the Editor - Observation Letter
Letter to the Editor - Study Letter
Letter to the Editor - Therapy Letter
Letter to the Editor: Articles in Response to Previously Published Articles
Letters in Response to Previous Publication
Letters to the Editor
Letters to the Editor - Letter in Response to Previously Published Articles
Letters to the Editor: Case Letters
Letters to the Editor: Letters in Response to Previously Published Articles
Medicolegal Window
Messages
Miscellaneous Letter
Musings
Net Case
Net case report
Net Image
Net Letter
Net Quiz
Net Study
New Preparations
News
News & Views
Obituary
Observation Letter
Observation Letters
Oration
Original Article
ORIGINAL CONTRIBUTION
Original Contributions
Pattern of Skin Diseases
Pearls
Pediatric Dermatology
Pediatric Rounds
Perspective
Presedential Address
Presidential Address
Presidents Remarks
Quiz
Recommendations
Regret
Report
Report of chief editor
Report of Hon : Treasurer IADVL
Report of Hon. General Secretary IADVL
Research Methdology
Research Methodology
Resident page
Resident's Page
Resident’s Page
Residents' Corner
Residents' Corner
Residents' Page
Retraction
Review
Review Article
Review Articles
Revision Corner
Self Assessment Programme
SEMINAR
Seminar: Chronic Arsenicosis in India
Seminar: HIV Infection
Short Communication
Short Communications
Short Report
Special Article
Specialty Interface
Studies
Study Letter
Supplement-Photoprotection
Supplement-Psoriasis
Symposium - Contact Dermatitis
Symposium - Lasers
Symposium - Pediatric Dermatoses
Symposium - Psoriasis
Symposium - Vesicobullous Disorders
SYMPOSIUM - VITILIGO
Symposium Aesthetic Surgery
Symposium Dermatopathology
Symposium-Hair Disorders
Symposium-Nails Part I
Symposium-Nails-Part II
Tables
Technology
Therapeutic Guidelines
Therapeutic Guidelines - IADVL
Therapeutics
Therapy
Therapy Letter
View Point
Viewpoint
What’s new in Dermatology
View/Download PDF
Guest Editorial
2012:78:1;17-18
doi: 10.4103/0378-6323.90941
PMID: 22199055

Vitiligo: Emerging paradigms

Davinder Parsad
 Department of Dermatology, PGIMER, Chandigarh, India

Correspondence Address:
Davinder Parsad
Department of Dermatology, PGIMER, Chandigarh
India
How to cite this article:
Parsad D. Vitiligo: Emerging paradigms. Indian J Dermatol Venereol Leprol 2012;78:17-18
Copyright: (C)2012 Indian Journal of Dermatology, Venereology, and Leprology

I must thank Prof. D. M. Thappa for preparing this issue focusing on vitiligo. Vitiligo is the most common depigmenting disorder having a major impact on the quality of life of patients. Despite continued progress toward an elucidation of the biochemical, genetic and immunopathological pathways in vitiligo, a definitive cure remains elusive. Although much research is ongoing in this field, there are still major limitations in current vitiligo research that are reflected in current treatment strategies. In this special issue, there are nine papers on vitiligo that review some of the crucial elements currently being investigated in this field, including three original articles.

Vitiligo has a profound effect on the quality of life of vitiligo patients, many of whom feel distressed and stigmatized by their condition. Ramam and Krishna emphasize in their editorial the need for a composite severity scale that should include psychosocial impact apart from disease progression and repigmentation potential. Focusing on enhancing self-esteem and improving quality of life in vitiligo patients should be an important part of the management of vitiligo. Camouflage has been shown to improve the quality of life in patients with vitiligo. Kaliyadan and Kumar provide a broad review on the different camouflage options available in vitiligo - products and techniques with their relative advantages and disadvantages.

Several theories have been proposed about the pathogenesis of vitiligo, but the precise cause behind melanocyte destruction remains unknown. Theories regarding the destruction of melanocytes include autoimmune mechanisms, cytotoxic mechanisms, an intrinsic defect of melanocytes, oxidant-antioxidant mechanisms and neural mechanisms. Recently, a new theory, melanocytorrhagy, has been proposed. According to this theory, depigmentation in vitiligo patches results from a chronic detachment of melanocytes called melanocytorrhagy, which is possibly related to increased susceptibility to mechanical and other types of stresses like chemical stress. Kumar and Parsad explore the relationship between apoptosis and melanocytorrhagy in the pathogenesis of vitiligo. In this review, they summarized all the theories for vitiligo with a focus on a new integrated theory that takes into account melanocyte detachment and transepidermal elimination, neural-biochemical and autoimmune hypotheses. The authors conclude that as there can be different pathomechanisms for different subtypes of vitiligo, melanocytorrhagy can play an important role in some subsets of vitiligo.

Boissy et al. describe an overview of the pathomechanism of vitiligo, emphasizing on the complex of vitiligo susceptibility genes that influence the autoimmune response and environmental or physiological factor(s) that activates the genetic program for melanocyte destruction. They further review how oxidative stress can come into play in the final removal of melanocytes. The authors point out that starting from the overlapping but distinct pathomechanisms, treatment should be finalized to the cellular targets and possibly related to the disease phase.

Childhood vitiligo deserves special attention as, frequently, the disease onset is before 20 years of age. Palit and Inamadar provide a comprehensive review on childhood vitiligo describing the epidemiology, clinical features, differential diagnosis and various treatment modalities, including surgical modalities. They also give due attention to vitiligo as a component of hereditary syndrome.

A critical appraisal of the current available treatment modalities of vitiligo points that we are still far away from an ideal weapon for vitiligo treatment. In the present era, we have a wide spectrum of many effective treatments for vitiligo; however, as an average and considering all affected anatomical locations, the best repigmentation rates do not reach figures beyond 70%, with acral regions and lesions with leucotrichia being the most difficult to repigment. Possibly, a combination of various treatment modalities could be a solution. Because the type, speed and stability of repigmentation in vitiliginous patches seem to depend on the type of treatment given, a combination of various available treatment options is indicated for therapeutically and cosmetically effective results.

Ultraviolet (UV) light-based therapy has been a mainstay of therapy for vitiligo for many decades. The earliest form was psoralen and UVA (PUVA) photochemotherapy. Currently, the most commonly used form is narrow-band ultraviolet B (NB-UVB) and, for limited areas, targeted phototherapy (excimer laser or excimer lamp). Hamzavi et al. provide a broad overview of phototherapy-based treatment modalities in vitiligo. They discuss the role of PUVA, NB-UVB and targeted therapy in vitiligo. They nicely cover this topic with patient selection, optimal dosing and recommendation.

Depigmentation therapy in vitiligo is an option in those with extensive vitiligo who have failed to respond to medical therapy and have obvious cosmetic disfigurement due to intervening patchy pigmented areas. Gupta et al. have written a review on the various depigmenting therapies, with an emphasis on patient selection, as various aspects of these therapies, such as the cost, treatment time, course, permanency of depigmentation, side-effects and the possibility of repigmentation, should first be discussed with the patient.

Non-cultured epidermal suspension (NCES) is emerging as the treatment of choice for surgical management of vitiligo because it can treat a large area with good color match and without any laboratory facilities. Gauthier and Benzekri describe the detailed method of NCES in the surgical management of vitiligo. They provide insight into several modifications that have been made to this procedure in order to make it faster, simpler and more effective. These modifications included use of DMEM media, hyaluronic acid, 6-well technique and cold trypsinization vs. hot trypsinization.

Kathuria et al. report a randomized trial of 60 patients with segmental vitiligo treated with tacrolimus 0.1% ointment twice daily or with 0.05% fluticasone cream once daily for 6 months. They found that both tacrolimus and fluticasone propionate produce variable but overall unsatisfactory repigmentation in segmental vitiligo.

To explore the details of phototherapy practices for vitiligo among dermatologists, Alghamdi et al. conducted a survey of dermatologists′ phototherapy practice. They observed that several variations exist in the approaches to and practice of phototherapy for vitiligo, including the types of phototherapy used for different types of vitiligo, dosage schedules, photoprotection, comparisons of different modalities and dermatologists′ management of adverse events.


Fulltext Views
406

PDF downloads
185
Show Sections